AJANTPHARM

Ajanta Pharma, a large-cap player in the Pharmaceuticals and Biotechnology sector. This change is primarily attributed to a shift in the technical grade, moving from a mildly bearish to a sideways trend. Currently, Ajanta Pharma's stock is priced at 2,624.80, up from the previous close of 2,540.85. The stock has experienced a 52-week high of 3,485.75 and a low of 2,022.05. Today's trading saw a high of 2,655.60 and a low of 2,550.00. In terms of performance, Ajanta Pharma has shown a return of 17.17% over the past year, significantly outperforming the BSE500 index, which returned 2.20%. However, the company has reported flat financial performance for Q4 FY24-25, with net sales growing at an annual rate of 12.43% and operating profit at 13.68% over the last five years. The company's management efficiency is notable, with a high return on equity (ROE) of 22.06% and a low debt-to-equity ratio.